The genes encoding apolipoprotein (apo) E and apoC1 are, together with the gene for apoC2, located in a conserved gene cluster on human chromosome 19q12-13.2 and mouse chromosome 7. Although the significance of apoE as a ligand for receptor-mediated uptake of lipoprotein remnant particles is undisputed, the in vivo function of apoC1 and the possible inter action between apoE and apoC1 in the modulation of plasma cholesterol and triglyceride levels is far from understood. Our strategy to unravel the metabolic relationship between apoE and apoC1 in vivo is to first generate mice deficient in both apolipoproteins, enabling future production of transgenic mice with variable ratios of normal and mutant apoE and apoC1 on a null background. Here we report the creation and characterization of mice deficient in both apoE and apoC1. As these genes are tightly genetically linked, double-deficient mice were obtained by two consecutive rounds of gene targeting in mouse embryonic stem cells. Surprisingly, double inactiva tion of the Apoe and Apoc1 gene loci as well as single inactivations at either one of these loci were found to affect also the RNA expression levels of the other gene members in the Apoe-c1-c2 cluster. This indicates that targeted insertions are not necessarily neutral for the expression of nearby gene members in a given gene cluster. Homozygous Apoe-c1 knockout mice are hypercholesterolemic, with serum choles terol levels of 12.5 ± 4.3 mM compared with 2.9 ± 0.5 mM in control mice, resembling mice solely deficient in apoE.
INTRODUCTION
The genes encoding apolipoprotein (apo) E and Cl, together with the pseudo APOCT gene and the gene for apoC2, are located within a 48 kb gene cluster on human chromosome 19qI2-19ql3. 2 (1). This entire linkage group is syntenic with a linkage group localized on mouse chromosome 7 (2) . Also the gene organization of individual genes within the cluster is highly conserved, with the exception that the mouse gene cluster is shorter and does not contain a pseudo A p o d ' gene (3) .
ApoE is a major structural component of various plasma lipoproteins, including chylomicrons, very low density lipopro teins (YLDL) and their remnants. It is synthesized primarily in the liver, although most tissues produce apoE to various extents. The major physiological role of apoE in lipoprotein metabolism is that it serves as a ligand for the receptormediated clearance of lipoprotein remnants by the liver (4) . Mutations in the APOE gene can lead to type III hyperlipoproteinaemia, a disease associated with premature atheroscler osis (5) . Mice deficient in apoE have been generated in our and other laboratories (6-8). These animals develop severe hypercholesterolaemia and atherosclerosis, with atherosclerotic lesions very similar to those observed in humans (9, 10) , ApoCl principally resides on chylomicrons, VLDL and high-density lipoproteins (HDL), and is also mainly produced by the liver (11) . In contrast to apoE, the in vivo function of apoCl is not well understood. We have reported previously that apoCl-deficient mice show an impaired receptor-mediated clearance of remnant lipoproteins (12) . Contrary, in vitro work demonstrated that apoCl can block the apoE-mediated uptake of (3-VLDL by hepatic receptors (13, 14) , suggesting that lack of apoCl would lead to an enhanced uptake of lipoprotein remnants by the liver. Studies in transgenic mice overexpressing overlapping human APOE and APOC1 containing genomic fragments identified several elements controlling the tissuespecific expression of these genes (15) . While the overexpres sion of APOC1 resulted in elevated levels of plasma cholesterol and triglyceride, the overexpression of both APOE and APOC1 under control of the same regulatory complex had no effect on plasma lipid levels (15) . This suggests that apoE and apoCl may interact coordinately to modulate the amount of plasma cholesterol and triglyceride (16) .
To investigate the metabolic relationship between apoE and apoCl in vivo, we plan to use transgenic mice with graded expression levels of the human APOE and APOC1 genes. To avoid interference of the endogenous mouse genes, the transgenic mice overexpressing the human genes should be bred with Apoe-cl double-knockout animals. We have previously generated mice lacking either apoE (6) or apoCl (12 3). One possibility to generate double-mutant mice would be to design a large deletion targeting vector, which upon homologous recombination would delete the Apoe and A p o d genes simultaneously. A similar approach has been used by Mombaerts and co-workers (17) , who deleted a 15 kb genomic segment of the T-cell antigen receptor P-subunit locus* A disadvantage of this strategy, however, is that regulatory elements could be deleted as well. Another approach would be to target the Apoe and A p o d genes sequentially. Because a heterozygous apo E-deficient embryonic stem (ES) cell line and a targeting vector for A p o d were already available, we chose the latter option.
The following questions were addressed. Is it possible to disrupt closely adjacent genes by consecutive rounds of gene targeting, and if yes, how do single or multiple insertions affect the mRNA expression of other nearby apolipoprotein gene members in the Apoe-d< 2 gene cluster? Furthermore, we were interested to know whether lack of apoC 1 in addition to lack of apoE would influence the severe hypercholesterolaemia observed in apoE-deficient mice (6-8).
Here we report that double-mutant mice are viable. Like apoE-deficient mice, homozygous Apoe-cl null mutants display hypercholesterol aemia, which becomes more severe on a high fat/cholesterol diet. Strikingly, the RNA expression levels of genes in the Apoe-cl-c2 gene cluster are affected by the targeted disruption of single {Apoe or A p o d ) or multiple {Apoe plus A p o d ) genes, indicating that targeted insertions are not necessarily neutral for the expression of nearby gene members in a given gene cluster.
RESULTS

Generation of apoE-Cl-deficient mice
A replacement-type targeting vector, as used previously to disrupt the A p o d gene (12) , was transfected into a hetero zygous apoE-deficient E l4 ES cell line (7) . This ES cell line was already resistant to G418, because a neomycin resistance (neor) gene had replaced exons 1 and 2 of the Apoe gene. To select for targeted clones, the A p o d targeting construct contained a hygromycin B resistance (hygroBr) cassette and a herpes simplex virus thymidine kinase (HSV-iA:) gene. The selection strategy is outlined in Figure 1 . In case the targeting of the A p o d gene takes place in the wild-type chromosome, the endogenous 8.0 kb band will disappear upon Southern blot analysis of Hindlll digested DNA with probe A. A 9,3 kb band for the targeted A p o d gene will become visible, next to - Effect of apoE-Cl-deficiency on apolipoprotein composition VLDL (d < 1.006 g/ml) and HDL (d ~ 1.063-1.21 g/ ml) were isolated from fasted wild-type, heterozygous and homozygous apoE-Cl -deficient animals by density ultracentri fugation, and subjected to SDS-polyacrylamide gel electro phoresis (SDS-PAGE) and protein staining (Fig. 3A) . In VLDL, apoE is clearly absent in the homozygous double mutant mice and reduced in the heterozygous animals. Instead, apoAl appears in the VLDL of homozygotes, whereas apoA4 is present in homozygous and heterozygous apoE-Cl -deficient mice. Most protein in HDL is apoAl. ApoB48 is normally not present in HDL, but because of high levels of VLDL/ LDL-sized particles (see also Fig. 4 ) residual amounts of these particles are also present in the 1.063-1.21 g/ml density fraction. Because a 4-20% gradient gel cannot distinguish between the different apoC proteins and apoA2, Western blotting was required to demonstrate that apoCl is absent in the homozygous and reduced in the heterozygous mutant mice (Fig. 3B ). When the filters were incubated with antibodies against apoE and apoB, similar results were obtained as with the gel stained for protein. The amount of apoC3 is comparable for all mice (Fig. 3B) .
Hypercholesterolaemia in apoE-C 1-deficient mice
As shown in Table 2 , apoE-C 1-deficient mice are severely hypercholesterolaemic on a chow diet, with average serum cholesterol levels of 12.5 ± 4.3 mM compared with 2.9 ± 0.5 mM in controls. Heterozygous double-deficient animals display normal serum lipid levels. There is no significant difference between male and female serum cholesterol levels.
To determine the distribution of cholesterol among the lipopro tein fractions, fast protein liquid chromatography (FPLC) analysis was performed on pooled fasted mouse sera (Fig, 4 , upper panel). In control and heterozygous mice, the main cholesterol carrier in serum is HDL, while at most 10% of total serum cholesterol is contained in the VLDL/LDL-sized fractions. In null mutants, however, most of the cholesterol (71%) is confined to the VLDL/LDL-sized fractions.
Upon feeding a mild high-fat/cholesterol (HFC) diet, con taining 15% fat and 0.25% cholesterol, serum cholesterol is increased eightfold in homozygous apoE-C 1 -deficient mice, as compared with controls fed the HFC diet (31 ± 10.1 mM and 3.8 ± 0.9 mM, respectively). The increase in total cholesterol is mainly found in the VLDL/LDL-sized fractions, as is depicted in the lower panel of Figure 4 .
DISCUSSION
This paper describes the generation of mice deficient in both apoE and apoCl by two consecutive rounds of gene targeting in ES cells. Because the Apoe and A p o cl genes are physically very close, and because the recombination distances across the pertinent area of mouse chromosome 7 are extremely small (2), double-deficient mice could not be obtained by cross breeding apoE-and apoCl-deficient mice. Instead, two selec tion markers (neor and hygroBr) were subsequently introduced into the same locus. The inactivation of the A p o d gene in the second round of gene targeting was very efficient (1 in 3-4), and comparable with the targeting frequency previously found in wild-type ES cells (12) . Both wild-type and already targeted alleles recombined with equal efficiency, indicating that the proximity of the neor gene in the apoE-deficient locus did not affect the frequency of homologous recombination. Moreover, the presence of both of these resistance genes and the two rounds of transfection and selection of the ES cells did not interfere with the germline potency of the cell line. While studying the mRNA levels of genes in the Apoe-cl-c2 gene cluster in apoE-, apoC-and double-deficient mice, some conspicuous observations were made. Not only is the expression of the targeted gene reduced by the respective mutation, also other genes in the cluster are influenced by the insertion of a targeting vector in the locus. There are several ways how this could occur. First, it is possible that a reduction of apoE protein would lead to a down-or upregulation of the A p o d or Apoc2 gene, or both, via an indirect metabolic effect in the lipoprotein metabolism. In that case, the amount of protein of the targeted gene would be critical for the effect on the expression of the other genes in the cluster. This type of metabolic interaction is seen in transgenic mice containing the gene for human cholesteryl ester transfer protein, in which the mRNA for the LDL receptor is down-regulated (18) . Second, the effect might be due to changes in genomic structure of the entire apolipoprotein cluster by the homologous integration of the targeting vectors. The insertion of one or two selection cassettes that include promoter and enhancer elements may deregulate the transcription of neighbouring genes in a distanceand position-dependent manner. Work in transgenic mice revealed that expression in liver of the human APOE and APOC1 genes requires a common m-acting regulatory domain, which is located about 9 kb downstream of the APOC1 promoter (19, 20) . A similar hepatic control element was identified in mice between A p o d and Apoc2 (J.Smith, pers, comm.). It is conceivable that the newly introduced promoter(s) and gene(s) (the hygroBr and neor genes, both driven off of the ffc-promoter and a mutant polyoma enhancer) will compete for this m-acting regulatory domain with apolipoprotein pro moters. Consequently, this would lead to reduced expression of these genes. A targeted insertion of a hygror cassette into the human |3-globin locus control region (LCR) in a mouse/ human hybrid erythroid cell line inactivated the downstream located p-globin gene (21) . The inactivation was suggested to be the result of interaction of LCR elements with the proximal enhancer/promoter introduced by the hygror cassette, pre venting the normal interaction between the LCR and the pglobin gene promoter. Similarly, competition between the genes in the Apoal -c3-a4 gene cluster for a shared regulatory sequence has been proposed by Maeda et ai (22) as an explanation for the observed reduction of expression of the Apoal and Apoa4 genes in intestine of homozygous apoC3deficient mice.
Which of the above mentioned options for the altered gene expression of the Apoe-cl-c2 cluster in the various knockout animals is true cannot be deduced from our data. A metabolic interaction between apoE and apoCl is quite feasible, because work in transgenic mice already suggested that these two proteins may interact coordinately to modulate plasma lipid levels (16) . Although there are multiple shared regulatory elements for the Apoe and A p o d genes (15) , it is not clear whether these elements also regulate the expression of Apoc2.
The integration of the targeting vector did not delete any of the known regulatory sequences. If the hepatic control region does not regulate the expression of Apoc2 but only controls the expression of Apoe and A p o d , then the reduced levels of these latter genes in the homozygous knockout mice could be explained by the competition model. As the expression of Apoc2 is decreased in homozygous apoCl -and double-deficient animals, normal in homozygous Apoe knockout mice and increased in heterozygous apoE-deficient mice, it is hard to explain these results with the competition model. If the expression of A p o d is regulated by the same ds-acting control region as the Apoe and A p o d genes, then the position of the enhancer relative to the gene (5' of Apoc2 and 3' of Apoe and A p o d ) and the distance between the enhancer and the gene might play a part.
The overt phenotype of the apoE-C 1 -deficient mice is similar to that of Apoe knockout mice (6-8), that is hypercholesterolaemia on a chow diet, which becomes more severe on a high-fat/cholesterol diet. Interestingly, heterozygous doubledeficient mice fed a chow diet display a lower serum cholesterol level than their wild-type littermates. This difference is signi ficant for males. This unexpected finding was also observed in heterozygous apoE-deficient mice fed a chow diet (6), although in that case the difference was only significant for females. At this moment, we do not know the reason for these observations.
On a chow diet, serum cholesterol levels in the double deficient mice seem to be somewhat lower than in apoEdeficient mice [12.5 ± 4.3 mM and 19.3 ± 5.5 mM (6), respectively], whereas serum cholesterol is comparable for both types of mice on the HFC diet. The difference on chow might be caused by difference in age between the apoEdeficient and the double-mutant mice, as we have previously shown that serum cholesterol in apoE-deficient mice is agedependent (6), but might also be due to absence of apoCl in addition to lack of apoE. It will be interesting to see whether these mice develop atherosclerosis to a similar extent as mice solely deficient in apoE (7) (8) (9) (10) , and if heterozygous Apoe-cl knockout mice fed a severe high-fat diet would also develop gender-dependent atherosclerosis, as we have observed in heterozygous Apoe null mutants (6).
When animals carrying a human transgene are studied, a null background of the mouse counterpart of that gene would be the ideal genetic environment of the study. Especially if the interaction between two transgenes is investigated, it is of great importance that there is no endogenous expression of these genes, so that there will be no compensatory up-or downregulation of the endogenous mouse genes. This can be reached by two rounds of crossbreeding of mice carrying a transgene with mice deficient in the endogenous protein of that gene. In this respect, the apoE-C 1-deficient mice are extremely valuable for future use in studies on the metabolic relationship between apoE and apoCl in vivo.
MATERIALS AND METHODS
Cell culture and transfection
An EI4 ES cell line with one functional and one disrupted Apoe allele (7, kindly provided by Dr A.S.PIump, Rockefeller University, New York) was used as the source of ES cells. The Apod gene was targeted with a replacement type vector designed to disrupt solely the Apod gene, as described previously (12) .
ES cells were cultured and subsequently selected on hygroBr mouse embryonic fibroblasts derived from mice deficient in muscle creatine kinase (23) . ES cells were electroporated in the presence of 25 pg/ml linearized vector DNA at 4.0 kV/cm in a TA750 transfection apparatus (Krilss GmbH Hamburg, Germany). Selection took place with 300 [ig/ml hygromycin B (ICN Biochemicals, Cleveland, OH) and 0.2 |iM FIAU (l-[2-deoxy, 2fluoro-p-D-arabinofuranosyl] 5-iodouracil), Bristol Myers, New York, NY) as described previously (12) .
Generation of chimeric and apoE-C 1-deficient mice
Targeted clones were injected into C57BL/6 recipient blastocysts and chimeras were obtained. Male chimeras were mated with C57BL/6 females, and germline transmission was scored by the presence of agouti fur in the offspring. Transmission of the Apoe-cl mutation was assessed by Southern blot analysis of tail tip DNA. Heterozygous mutants were interbred to obtain homozygous apoE-C 1-deficient mice. Animals were bred and housed under standard conditions in the transgenic animal facilities of the Central Animal Laboratory of the Medical Faculty, Nijmegen University.
Genomic Southern blot analysis
ES cell clones were lysed in 0.5 ml of 0.5 M Tris-HCI, pH 9.0, 20 mM EDTA, 10 mM NaCl, 1% SDS and 100 |ig/ml proteinase K at 55°C overnight. DNA was purified by phenol extraction and ethanol precipitation. Tail tip DNA was prepared as previously described (6).
Aliquots of approximately 5 fig of DNA were digested with Hindill and DNA fragments were resolved on 0,7% (w/v) agarose gels, transferred to Biotrace HP nylon membranes (Gelman Sciences, Ann Arbor, MI) and hybridized to a genomic probe A, which is located 5' to the targeting vector (see Fig. 1 ). Genomic probes were isolated by random subcloning of a Sau3A digested cosmid, carrying the Apoe-cl-c2 cluster.
Northern blot analysis
Total RNA wus isolated individually from three to four livers per genotype using the RNAZOL procedure (Cinna/Biotecx, Houston), Each RNA sample was loaded on to four individual gels. RNA samples (10 pg per lane) were size separated by electrophoresis through a denaturing agarose gel (1% w/v) containing 7.5% formaldehyde and transferred to a nylon membrane (Hybond N+, Amersham) according to the manufacturer's recommendations. Blots were subsequently hybridized with 32P-labelled mouse cDNA probes for Apoe 
Lipoprotein isolation
The individual lipoprotein fractions (VLDL:
1.006; IDL+LDL: d = 1.006-1.063; HDL: d ~ 1.063-1.21 g/ml) were isolated from pooled serum by sequential ultracentrifugation, as previously described (12) . The amount of protein was determined according to Lowry (27) .
For FPLC size fractionation of lipoproteins, 200 ju.1 of pooled serum from at least nine fasted mice per group was injected on to a 25 ml Superose 6 prep grade column (Pharmacia, Uppsala, Sweden), and eluted at a constant flow rate of 0.5 ml/min with PBS (pH 7.4). The effluent was collected in 0.5 ml fractions, and cholesterol and triglyceride concentrations were measured enzymatically in each fraction, as described in 'lipid and lipoprotein analyses'. The lipoproteins were identified on the basis of the elution profile of human serum lipoproteins.
SDS-PAGE and Western blot analyses
For SDS-PAGE mouse VLDL and HDL was loaded on a 4-20% gradient gel. Proteins were detected by staining with Coomassie blue. For Western blot analysis samples of VLDL-protein were size-separated by SDS-PAGE using 4-20% gradient gels. Proteins were transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) followed by incubation with polyclonal rabbit anti-mouse apoCl, apoC3 and apoE (kindly provided by Dr K.Weisgraber, Gladstone Foundation Laboratories for Cardiovascular Disease, San Francisco, CA) and with rabbit antimouse apoB. Goat antirabbit IgG conjugated to peroxidase (Nordic Immunology, Tilburg, the Netherlands) was used as a second antibody and detection was performed by the immunoperoxidase procedure, using 4-chloro-l-naphtol as substrate.
Lipid and lipoprotein analyses
After an overnight fasting period (16-17 h) , approximately 150 jl l I of whole blood was obtained from each individual mouse through tail bleeding. Levels of total serum cholesterol and triglyceride (without measuring free glycerol) were determined using Boehringer Mannheim enzymatic assay kit #236691 and Sigma GPO-Trinder kit #337~B, respectively.
Diets
Mice were given free access to water and food. A regular breeding chow diet (RMH-B) containing 6.2% fat and a semisynthetic mild HFC diet containing 15% cocoa butter, 0.25% cholesterol, 40,5% sucrose, 10% cornstarch, 1% corn oil, and 6% cellulose (all percentages are by weight) were used. The latter diet was composed essentially according to Nishina and co-workers (28) . Diets were purchased from Hope Farms, Woerden, the Netherlands.
